Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Mesenchymal stem cell Stories

2012-09-08 23:01:31

A new pre-clinical study demonstrates how stem cells may significantly reduce the ripple-effect damage caused by a heart attack. The study, by researchers at the University of Maryland School of Medicine in Baltimore, appears in the September issue of STEM CELLS Translational Medicine. Durham, NC (PRWEB) September 07, 2012 A new pre-clinical study demonstrates how stem cells may significantly reduce the ripple-effect damage caused by a heart attack. The study, by researchers at the...

2012-09-04 10:24:29

SEOUL, South Korea, Sept. 4, 2012 /PRNewswire/ -- Korean researchers, reporting the results of a major study in the Circulation Journal, found that the transplantation adipose (fat) derived stem cells resulted in the regeneration of blood vessels in patients who were otherwise expecting to receive limb amputations due to damaged arteries and lack of blood circulation. Researchers at Pusan National University, led by Dr. Han Cheol Lee, describe how patients with critical limb ischemia...

2012-08-30 18:20:54

SEOUL, South Korea, Aug. 31, 2012 /PRNewswire/ -- In a landmark clinical study, scientists of the RNL Stem Cell Technology Institute have demonstrated that the transplant of patients' own ("autologous") stem cells can dramatically improve the ability of plastic surgeons to repair diseases. In the September 2012 issue of the prestigious international plastic surgery journal Annals of Plastic Surgery (69:3), researchers published their controlled study of the power of stem cells, describing a...

2012-08-15 23:00:07

Stemedica International, SA (Epalinges, Switzerland), a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (“Stemedica”), a leader in adult stem cell research and manufacturing, announced today that it has been granted a series of licenses by Swissmedic (the Swiss equivalent of the United States Food and Drug Administration). These licenses specifically authorize the Company to import and export its Stemedyne stem cell products worldwide for human use in approved...

2012-08-13 13:01:54

Duke researchers may have found a promising stem cell therapy for preventing osteoarthritis after a joint injury. Injuring a joint greatly raises the odds of getting a form of osteoarthritis called post-traumatic arthritis, or PTA. There are no therapies yet that modify or slow the progression of arthritis after injury. Researchers at Duke University Health System have found a very promising therapeutic approach to PTA using a type of stem cell, called mesenchymal stem cells (MSCs), in...

2012-08-10 23:00:06

IRMO is a leader in traditional orthopedics and cutting-edge innovations in regenerative medicine. The newest breakthrough is performing stem cell harvesting and isolation of adipose mesenchymal stem cells. Boca Raton, FL (PRWEB) August 10, 2012 The Institute of Regenerative and Molecular Orthopedics announced this week that it is one of the few centers performing stem cell harvesting and isolation of adipose mesenchymal stem cells. The procedure could lead to the newest frontier in tissue...

2012-07-25 10:23:40

FARMINGTON, Conn., July 25, 2012 /PRNewswire-iReach/ -- Businesses looking to capture a larger slice of the lucrative mesenchymal stem cell product market need the best market research to stay ahead of the competition. Global Information Inc, in partnership with research firm BioInformant Worldwide, is pleased to present three new reports on stem cells and regenerative medicine. This new research will help businesses in the stem cell industry understand their customers by providing insight...

2012-07-23 18:20:31

MELBOURNE, Australia, July 23, 2012 /PRNewswire/ -- Key Points: * Intravenous injection of Mesenchymal Precursor Cells (MPCs) resulted in selective migration to inflamed joints and lymph nodes in a sheep model of Rheumatoid Arthritis (RA) * A single intravenous injection of allogeneic, or "off-the-shelf", MPCs significantly reduced synovial tissue levels of TNF-alpha, IL-6, and IL-17, and reduced mononuclear cell infiltration * Reduced cytokine and inflammatory cell levels were...

2012-06-27 14:22:16

HOUSTON, June 27, 2012 /PRNewswire/ -- After an invitation from Celltex Therapeutics Corp., the Food and Drug Administration (FDA) visited the Celltex laboratory for two weeks in April, 2012. The FDA studied Celltex operations in depth in accordance with the "good tissue practices" (GTP) standards, as it routinely does with inspections of facilities such as Celltex which are registered pursuant to 21 CFR Part 1271. In their close-out report given to Celltex on the last day of their visit,...

2012-06-13 06:24:49

Corporate Member relationship will further support AlloSource's leadership in the healthcare industry CENTENNIAL, Colo., June 13, 2012 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's leading non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone growth substitutes, today announced that LifeGift in Houston, Texas will join AlloSource as its newest Corporate Member. The AlloSource...